Is this the End of the American Appetite?

Thursday, May 28, 2026. 3:21 pm.

There was a period in American life when appetite itself was treated as evidence of character.

Big hunger meant ambition.
Big consumption meant vitality.
Big personalities ordered appetizers “for the table” with the confidence of Roman emperors moments before everyone developed acid reflux and unresolved emotional dependency.

The culture admired wanting.

Wanting more.
Buying more.
Eating more.
Scrolling more.
Achieving more.
Experiencing more.

American life became organized around stimulation so thoroughly that many people stopped noticing the machinery surrounding them.

The grocery store. The smartphone. The liquor aisle. The food delivery app.

The casino mechanics embedded into social media notifications. The endless frictionless architecture of modern consumption.

Because I’m a couples therapist, I have become increasingly aware that many partners do not merely organize their lives around appetite. They organize their identities around it.

Couples eat together.
Drink together.
Impulse-spend together.
Stress-regulate together.
Reward themselves together.
Doomscroll together.

Craving becomes relational.

And now something culturally strange is happening.

Millions of people are taking Ozempic, Wegovy, and Mounjaro, and the conversation is no longer merely about weight loss.

The real story is this:

GLP-1 drugs may be the first mass-market medications that visibly alter the emotional texture of wanting itself.

Morgan Stanley estimates the number of Americans using GLP-1 medications could reach 24 million by 2035. That is not a niche medical trend. That is a population-level psychological event.

If this sounds familiar, you are not alone.

More folks are beginning to notice that the modern attention economy has quietly merged appetite, identity, and emotional regulation into one exhausting system.

The Restaurant Table

A woman sits across from her husband at a restaurant in Boston.

For fifteen years, Friday nights looked roughly the same:
cocktails,
fried appetizers,
dessert they “weren’t supposed to get,”
a little joking guilt,
a little pleasure,
a little exhaustion afterward.

The ritual mattered more than the food itself.

Now she pushes a fork through grilled salmon while her husband orders the old familiar sequence automatically:
beer.
nachos.
another beer.
dessert menu.

“You’re not hungry?” he asks.

“I guess not.”

But what she cannot quite explain is this:
she no longer misses the wanting.

And that absence feels psychologically disorienting.

Not triumphant.
Not tragic.
Just strange.

Like walking into a room where a machine has finally stopped humming after years of background noise.

The New Language of GLP-1 Culture

The first phase of GLP-1 discourse was medical.

Blood sugar.
A1C levels.
Insulin sensitivity.
Cardiovascular outcomes.

The second phase was aesthetic.

Celebrity speculation.
“Ozempic face.”
“Ozempic teeth.”
Luxury thinness.
Status signaling.

But now the conversation has mutated into something far more psychologically revealing.

People increasingly say things like:

• “The food noise disappeared.”

• “I stopped impulse shopping.”

• “I don’t drink much anymore.”

• “I stopped obsessing over snacks.”

• “I don’t compulsively scroll late at night.”

• “My brain feels quieter.”

• “I didn’t realize how much of my personality revolved around craving.”

This is no longer ordinary diet culture.

This is desire quieting.

And desire quieting reaches far beyond food.

Because appetite is partly attentional. What human beings repeatedly notice, fantasize about, rehearse emotionally, and anticipate eventually becomes desire. Modern technology companies understand this with near-religious precision.

The notification.
The snack.
The purchase.
The swipe.
The reward uncertainty.
The next hit.

Large sectors of the modern attention economy profit from emotional dysregulation, compulsive engagement, and reward-seeking behavior.

America spent decades industrializing craving.

GLP-1 drugs may become the first mass-market technology designed to industrially suppress it.

The Grocery Store Feeling

A client described standing in a grocery store staring at shelves he once found irresistible.

The brightly colored snacks.
The frozen food aisle.
The candy near checkout.
The little dopamine architecture of modern retail.

And suddenly nothing was calling to him anymore.

Not morally.
Not heroically.
Just… quietly.

He described feeling unexpectedly emotional afterward.

Not because he missed junk food exactly.

But because he realized how much emotional companionship existed inside the ritual of wanting it.

This is the part of GLP-1 culture people are only beginning to discuss publicly:

many users are not merely losing weight.

They are losing emotional rituals.

And that , for some, can produce grief.

The Spiritual Language Emerging Around Ozempic

One of the strangest developments online is how often people describe GLP-1 medications using language that sounds almost monastic.

Not:
“I lost twenty pounds.”

But:
“The chatter stopped.”
“I finally felt calm.”
“My mind became quiet.”
“I no longer feel possessed by cravings.”

Historically, religious traditions have spent thousands of years wrestling with appetite:

• fasting.

• asceticism.

• contemplative restraint.

• sobriety rituals.

• monastic discipline.

Now pharmacology appears capable of influencing some of those same systems biologically.

And that creates a fascinating cultural tension.

Because Americans traditionally romanticize appetite.

Big dreams.
Big personalities.
Big striving.
Big indulgence.

Desire itself became patriotic.

So when millions of people suddenly describe reduced craving as psychologically liberating, the culture becomes uneasy.

The internet immediately begins searching for hidden costs.

“Ozempic face.”
“Ozempic teeth.”
Muscle loss.
Aging.
Emotional flattening.
Loss of pleasure.
Reduced libido.

Every civilization invents cautionary folklore around transformational technologies.

Especially technologies that appear:

• too powerful.

• too fast.

• too efficient.
  or

• insufficiently earned.

The body becomes the symbolic battlefield where anxiety gets projected.

The subtext becomes:
“There must be a price.”

Prozac, Cigarettes, Adderall, and the Pharmacology of Selfhood

America has seen versions of this anxiety before.

Cigarettes once symbolized sophistication, appetite suppression, and emotional regulation simultaneously.

Prozac triggered fears that antidepressants might chemically alter identity itself.

Adderall blurred the line between treatment and performance enhancement.

Silicon Valley later reframed optimization as virtue:
better focus.
better productivity.
better cognition.
better self-management.

GLP-1 culture now enters this same historical stream.

Except this time the target is appetite itself.

And appetite is deeply entangled with:

• pleasure.

• identity.

• reward.

• sexuality.

• consumption.

• emotional regulation.

Which is why the conversation feels so psychologically charged.

Life partners are not merely asking:
“Will this make me thinner?”

They are asking:
“What happens if pharmacology changes the structure of wanting?”

Relationships in the Age of Pharmacological Appetite

This may become one of the least discussed but most important relational shifts of the next decade.

Because couples frequently organize intimacy around synchronized appetites.

Shared meals.
Shared drinking rituals.
Shared indulgence.
Shared consumption patterns.
Shared reward cycles.

Many couples quietly mistake shared appetites for compatibility.

That sentence sounds simple until you watch what happens when one partner changes rapidly while the relationship system remains emotionally organized around the old rituals.

A husband notices his wife no longer wants wine at night.
A wife notices her husband no longer binge eats while watching television.
A partner suddenly develops stronger boundaries around emotional eating, impulsive spending, or compulsive socializing.

At first, the untreated partner often interprets the shift behaviorally:
“She’s eating less.”
“He stopped drinking.”
“She’s healthier now.”

But beneath the surface, something larger is often happening.

The emotional choreography of the relationship is changing.

Many couples possess what could be called synchronized dysregulation:
shared reward systems that stabilize the relationship through mutual indulgence, distraction, sedation, stimulation, or ritualized excess.

Take away the shared appetite and the emotional structure underneath becomes visible.

One partner may experience:

• freedom.

• clarity.

• reduced compulsivity.

• emotional quiet.

The other may experience:

• abandonment.

• envy.

• judgment.

• insecurity.

• attraction shifts.

• fear of asymmetrical self-development.

This pattern usually escalates when couples moralize the transformation instead of understanding it systemically.

Insight is not interruption.

And many relationships are about to discover how much of their intimacy depended upon shared appetite architecture.

The Quieting of Consumer Desire

The economically disruptive part of GLP-1 culture may not be thinner bodies.

It may be quieter consumers.

Many users report reduced interest not only in food, but also:

• alcohol.

• shopping.

• gambling,

• impulsive online spending.

• compulsive scrolling.

• high-reward novelty seeking generally.

Imagine the implications of a population that:

• buys less impulsively.

• drinks less.

• binges less.

• doomscrolls less.

• experiences less compulsive reward-seeking.

That is not merely a public health shift.

That is potentially an economic shift.

Modern digital life increasingly resembles a giant behavioral casino built atop variable reward schedules:
likes.
notifications.
sales.
feeds.
algorithmic stimulation.
frictionless purchasing systems.
emotionally engineered attention loops.

The economy often functions by converting agitation into consumption.

Which raises an uncomfortable possibility:

certain industries may depend upon keeping human beings psychologically overstimulated.

The Grief Beneath the Transformation

The most interesting GLP-1 stories are often not:
“I became hotter.”

They are:
“I no longer recognize the emotional architecture of my old life.”

Because many people are not simply losing weight.

They are losing:

• coping systems.

• rituals.

• emotional anesthesia.

• reward loops.

• familiar identities.

• social synchronization.

One client described opening a food delivery app after a stressful day at work before suddenly realizing:
she no longer wanted anything.

Not pizza.
Not comfort food.
Not even dessert.

And instead of relief, she felt grief.

Because for years the ritual itself had functioned as emotional companionship.

The wanting had rhythm.
The anticipation had structure.
The reward cycle had familiarity.

Now the ritual was gone.

And underneath it sat silence.

The Larger Fear Beneath the Conversation

The deepest fear surrounding GLP-1 culture may ultimately be this:

if desire can be medically modulated,
what else about the self is negotiable?

Not merely body weight.

But:
motivation.
ambition.
pleasure.
risk-taking.
sexuality.
consumer behavior.
novelty seeking.
personality.
identity itself.

Social media circles this question constantly now, even when disguised as humor.

Because people increasingly suspect many of their desires were never entirely theirs to begin with.

Algorithms shaped them.
Ultra-processed food shaped them.
Advertising shaped them.
Infinite-scroll systems shaped them.

So GLP-1 drugs arrive at an extraordinarily strange historical moment.

They are perceived simultaneously as:

• liberation.
  and

• control.

Freedom from compulsive appetite.
Pharmacological management of desire.
Possibly both.

And that ambiguity is precisely why the discourse feels so emotionally electric.

FAQ

Are GLP-1 drugs like Ozempic changing personality?

There is currently no definitive evidence that GLP-1 medications directly change personality. However, many users report significant changes in:

• cravings.

• compulsive behaviors.

• reward sensitivity.

• alcohol use.

• shopping impulses.

• emotional regulation.

Because desire is deeply connected to identity and routine, these shifts can feel psychologically transformative.

Why do people say Ozempic quiets “food noise”?

“Food noise” is an informal phrase describing persistent intrusive thoughts about food, cravings, or reward anticipation. Many users report these thoughts become dramatically quieter while taking GLP-1 medications.

Can GLP-1 medications affect addictive behaviors?

Emerging research suggests GLP-1 receptor agonists may influence reward pathways associated with addictive behaviors, including alcohol use and compulsive reward-seeking.

Why has Ozempic culture become so emotionally charged online?

Because the discussion now touches:

• identity.

• morality.

• beauty.

• self-control.

• capitalism.

• emotional regulation.

• desire itself.

The drugs became symbolic far beyond weight loss.

Could GLP-1 drugs change relationships?

Potentially yes. Appetite, alcohol rituals, consumption patterns, reward systems, and emotional soothing behaviors are often deeply embedded inside relationship systems. Significant changes in those behaviors can alter relationship dynamics unexpectedly.

Final Thoughts

A man stands in a grocery store late at night holding a family-sized bag of chips he would have automatically purchased six months earlier.

The fluorescent lights hum softly overhead.
A freezer compressor rattles nearby.
An advertisement flickers across a digital checkout screen promising “indulgence without regret,” which increasingly feels like the unofficial slogan of modern civilization.

But something has changed.

The craving is gone.

Not conquered heroically.
Not suppressed violently.

Just absent.

And for one brief moment, he realizes how much of his emotional life had once been organized around anticipation itself.

The wanting.
The ritual.
The tiny surge of comfort before the comfort even arrived.

He places the bag back on the shelf.

Then he stands there a moment longer than necessary, strangely unsure whether he has lost something…

or whether freedom and loss had quietly become the same thing.

Be Well, Stay Kind, and Godspeed.

REFERENCES:

Holst, J. J. (2019). The physiology of glucagon-like peptide 1. Physiological Reviews, 99(4), 2083–2148. https://doi.org/10.1152/physrev.00034.2018

Kalra, S., & Gupta, Y. (2023). GLP-1 receptor agonists and the brain: Implications for addiction and reward pathways. Diabetes Therapy, 14(4), 879–892. https://doi.org/10.1007/s13300-023-01378-0

Meier, J. J. (2021). GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nature Reviews Endocrinology, 17(12), 728–742. https://doi.org/10.1038/s41574-021-00555-w

Volkow, N. D., & Blanco, C. (2023). The changing neurobiology of addiction and obesity. New England Journal of Medicine, 389(9), 781–783. https://doi.org/10.1056/NEJMp2305508

Yuan, M., Crossley, D. M., & Leslie, F. M. (2023). GLP-1 receptor agonists and addiction-related behaviors: Emerging evidence and future directions. Addiction Biology, 28(6), e13321. https://doi.org/10.1111/adb.13321